527 related articles for article (PubMed ID: 17917544)
1. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections.
Vassilopoulos D; Calabrese LH
Curr Opin Rheumatol; 2007 Nov; 19(6):619-25. PubMed ID: 17917544
[TBL] [Abstract][Full Text] [Related]
2. Rheumatic manifestations of hepatitis.
Vassilopoulos D; Manolakopoulos S
Curr Opin Rheumatol; 2010 Jan; 22(1):91-6. PubMed ID: 19864952
[TBL] [Abstract][Full Text] [Related]
3. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
Zingarelli S; Frassi M; Bazzani C; Scarsi M; Puoti M; Airò P
J Rheumatol; 2009 Jun; 36(6):1188-94. PubMed ID: 19447932
[TBL] [Abstract][Full Text] [Related]
4. Biologic agents in the treatment of rheumatic diseases with chronic viral infection. Where are we?
Wendling D; Di Martino V; Herbein G
J Rheumatol; 2009 Jun; 36(6):1107-8. PubMed ID: 19509089
[No Abstract] [Full Text] [Related]
5. [Immunosupression and viral infections in rheumatic diseases].
Vince A; Dusek D
Reumatizam; 2007; 54(2):58-62. PubMed ID: 18351141
[TBL] [Abstract][Full Text] [Related]
6. Rituximab-associated infections.
Gea-Banacloche JC
Semin Hematol; 2010 Apr; 47(2):187-98. PubMed ID: 20350666
[TBL] [Abstract][Full Text] [Related]
7. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature.
Domm S; Cinatl J; Mrowietz U
Br J Dermatol; 2008 Dec; 159(6):1217-28. PubMed ID: 18945310
[TBL] [Abstract][Full Text] [Related]
8. Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases.
Louthrenoo W
Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):319-42. PubMed ID: 26362747
[TBL] [Abstract][Full Text] [Related]
9. Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes.
Vassilopoulos D
Eur J Intern Med; 2011 Dec; 22(6):572-5. PubMed ID: 22075282
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies.
Keane J; Bresnihan B
Curr Opin Rheumatol; 2008 Jul; 20(4):443-9. PubMed ID: 18525359
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management.
Lubel JS; Testro AG; Angus PW
Intern Med J; 2007 Oct; 37(10):705-12. PubMed ID: 17894766
[TBL] [Abstract][Full Text] [Related]
12. Infectious complications of biological therapy.
Haroon N; Inman RD
Curr Opin Rheumatol; 2009 Jul; 21(4):397-403. PubMed ID: 19412102
[TBL] [Abstract][Full Text] [Related]
13. Oral manifestations of viral infections in immunocompromised patients.
Schubert MM
Curr Opin Dent; 1991 Aug; 1(4):384-97. PubMed ID: 1666308
[TBL] [Abstract][Full Text] [Related]
14. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.
Calabrese LH; Zein N; Vassilopoulos D
Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii18-ii24. PubMed ID: 15479865
[TBL] [Abstract][Full Text] [Related]
15. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.
Carroll MB; Bond MI
Semin Arthritis Rheum; 2008 Dec; 38(3):208-17. PubMed ID: 18221983
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
Juan J; Feld JJ
Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients].
von Wagner M; Zeuzem S
Dtsch Med Wochenschr; 2009 Feb; 134(6):255-8. PubMed ID: 19180418
[TBL] [Abstract][Full Text] [Related]
18. Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.
Kohrt HE; Ouyang DL; Keeffe EB
Clin Liver Dis; 2007 Nov; 11(4):965-91, x. PubMed ID: 17981237
[TBL] [Abstract][Full Text] [Related]
19. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
Cheruvu S; Marks K; Talal AH
Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
[TBL] [Abstract][Full Text] [Related]
20. Treatment of rheumatic diseases in patients with HCV and HIV infection.
Galeazzi M; Giannitti C; Manganelli S; Benucci M; Scarpato S; Bazzani C; Caporali R; Sebastiani GD
Autoimmun Rev; 2008 Dec; 8(2):100-3. PubMed ID: 18694850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
